Using digital devices to diagnose cognitive disorders in elderly patients.
Interest of Two Digital Devices for the Diagnosis of Neurocognitive Disorders in Elderly People With Cognitive Symptoms.
This study is testing if using a tablet and smartwatch can help doctors better diagnose cognitive disorders in older adults who are having memory or thinking problems.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 150 (estimated) |
| Ages | 60 Years to 110 Years |
| Sex | All |
| Sponsor | Rivages Academic / other |
| Locations | 2 sites (Ballainvilliers, Essonne and 1 other locations) |
| Trial ID | NCT06032611 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to compare traditional clinical assessments with data collected from two digital devices—a tablet and a smartwatch—to diagnose neurocognitive disorders in elderly individuals experiencing cognitive symptoms. Participants will complete cognitive tasks and questionnaires while wearing a smartwatch for one week to gather physiological data. The study will categorize participants into three groups based on their cognitive function: no dysfunction, mild neurocognitive impairment, and major neurocognitive disorder. The goal is to create a reliable diagnostic tool that aligns with established clinical diagnoses.
Who should consider this trial
Good fit: Ideal candidates include elderly individuals consulting a memory center with documented cognitive diagnoses or no cognitive dysfunction.
Not a fit: Patients with conditions affecting hand function or other illnesses causing cognitive decline may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved early detection and diagnosis of neurocognitive disorders, allowing for timely interventions.
How similar studies have performed: Other studies have shown promise in using digital tools for cognitive assessment, but this specific approach is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * elderly people consulting the memory center ; * people with one of three documented cognitive diagnoses: * major neurocognitive impairment due to Alzheimer's disease according to DSM-5 criteria, * mild neurocognitive impairment * no documented cognitive dysfunction after assessment at the memory center, * willingness to participate in the study and sign the consent form. Exclusion Criteria: * persons with an illness affecting the hand (orthopedic, neurological, Parkinson's disease) that prevents them from using a touch-sensitive tablet; * persons with other illnesses that may be responsible for loss of cognitive function (cerebrovascular disease, other neurological illnesses, psychiatric illnesses); * persons benefiting from legal protection.
Where this trial is running
Ballainvilliers, Essonne and 1 other locations
- Hôpital Privé Gériatrique Les Magnolias — Ballainvilliers, Essonne, France (Recruiting)
- Hôpital Charles Foix — Ivry-sur-Seine, Val De Marne, France (Recruiting)
Study contacts
- Study coordinator: Joël Belmin
- Email: j.belmin@aphp.fr
- Phone: 0149594565
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.